A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

BACKGROUND: The most frequently diagnosed primary brain tumor is glioblastoma (GBM). Nearly all patients experience tumor recurrence and up to 90% of which is local recurrence. Thus, increasing the therapeutic ratio of radiotherapy using hypofractionated stereotactic radiotherapy (HSRT) can reduce t...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Yun, Pan, Mingyuan, Yang, Jun, Lu, Qiuxia, Han, Liangfu, Liu, Ying, Li, Jing, Zhu, Huaguang, Gong, Xiu, Mei, Guanghai, Liu, Xiaoxia, Pan, Li, Dai, Jiazhong, Wang, Yang, Wang, Enmin, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335974/
https://www.ncbi.nlm.nih.gov/pubmed/35906549
http://dx.doi.org/10.1186/s12885-022-09914-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335974/
https://www.ncbi.nlm.nih.gov/pubmed/35906549
http://dx.doi.org/10.1186/s12885-022-09914-5

Ejemplares similares